Printer Friendly

New method to turn blood-brain barrier into therapy delivery system.

Byline: ANI

London, Sep 22 (ANI): Researchers at University of Iowa have discovered a way to turn the blood brain barrier into a production and delivery system for getting therapeutic molecules directly into brain cells.

Working with animal models of a group of fatal neurological disorders called lysosomal storage diseases, the researchers found that these diseases cause unique and disease-specific alterations to the blood vessels of the blood brain barrier.

The scientists used these distinct alterations to target the brain with gene therapy, which reversed the neurological damage caused by the diseases.

The findings could lead to a new non-invasive approach for treating neurological damage caused by lysosomal storage diseases.

"This is the first time an enzyme delivered through the bloodstream has corrected deficiencies in the brain. This provides a real opportunity to deliver enzyme therapy without surgically entering the brain to treat lysosomal storage diseases," Nature quoted lead investigator Beverly Davidson as saying.

"In addition, we have discovered that these neurological diseases affect not just the brain cells that we often focus on, but also the blood vessels throughout the brain. We have taken advantage of that finding to delivery gene therapy, but we also can use this knowledge to better understand how the diseases impact other cell types such as neurons," she added.

Lysosomal storage diseases are caused by deficiencies in enzymes that break down larger molecules. Without these enzymes, the large molecules accumulate inside cells and cause cell damage and destruction.

Enzyme replacement therapy has been successful in treating one form of lysosomal storage disease called Gaucher disease.

However, storage diseases that affect the central nervous system remain untreatable because it has not been possible, to this point, to get the missing enzymes past the blood-brain-barrier and into the brain.

"Our discovery allowed us to test the idea that the brain cells might be able to make use of the reintroduced enzyme to stop or reverse the damage caused by the accumulated materials. In the treated mice, the affected brain cells go back to looking normal, the brain inflammation goes away and the impaired behaviours that these mice have is corrected," said Davidson.

The study was published in Nature Medicine's Advance Online Publication (AOP). (ANI)

Copyright 2009 Asian News International (ANI) - All Rights Reserved.

Provided by an company
COPYRIGHT 2009 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Asian News International
Date:Sep 22, 2009
Previous Article:Scientists use creativity and models in problem solving.
Next Article:Single mothers were "never part of evolution".

Related Articles
Particles enter the nervous system via the nose.
Breaking the barrier: a technique combining ultrasound pulses with microbubbles may help scientists move therapeutic drugs across the brain's...
The blood brain barrier.
Macromolecular drug delivery; methods and protocols.
Aerosol spray may help prevent death of brain cells after stroke.
Inflammation may lead to Alzheimer's disease.
Raptor Pharmaceuticals to collaborate with Roche on therapeutic delivery across blood-brain barrier.
Study finds a possible protein link between osteoporosis, hot flashes: bone-growth regulator can also act as a thermostat in mice.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters